Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

GREG IRVING

Research output: Contribution to journal › Article (journal) › peer-review

3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences